What does APOTHEEK HAVENDAM do?

APOTHEEK HAVENDAM is a pharmacy in Brugge. Private Limited, started on 24 May 2007, 1 establishment.

What is the address of APOTHEEK HAVENDAM?

The registered office of APOTHEEK HAVENDAM is located at Kustlaan 161, 8380 Brugge.

Is APOTHEEK HAVENDAM still active?

Yes. According to the CBE (30 October 2026) APOTHEEK HAVENDAM is active, legal situation “Normale toestand”, started on 24 May 2007.

Is APOTHEEK HAVENDAM registered on Peppol?

Yes, APOTHEEK HAVENDAM is registered on the Peppol network with ID 0208:0889942633.

What is the enterprise number of APOTHEEK HAVENDAM?

The enterprise number of APOTHEEK HAVENDAM is BE0889942633.

When was APOTHEEK HAVENDAM founded?

APOTHEEK HAVENDAM was founded on 24 May 2007.

Who are the directors of APOTHEEK HAVENDAM?

According to the 2025 annual accounts, the directors of APOTHEEK HAVENDAM are: Pic-Quick BV.

Is APOTHEEK HAVENDAM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 May 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK HAVENDAM make in 2025?

APOTHEEK HAVENDAM posted a profit after taxes of € 28,512 in financial year 2025.

What is the revenue of APOTHEEK HAVENDAM?

As a small company, APOTHEEK HAVENDAM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 93,021.

How much does an employee at APOTHEEK HAVENDAM earn?

The average wage cost per full-time employee at APOTHEEK HAVENDAM was € 69,000 in 2023: staff costs of € 69,017 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK HAVENDAM have?

According to the 2025 annual accounts, APOTHEEK HAVENDAM has 0.8 full-time equivalents (FTE).

APOTHEEK HAVENDAM (Private Limited) - Brugge

Dossier APOTHEEK HAVENDAM, printed on 30 October 2026 from databakkes.be/en/0889942633/apotheek-havendam. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 1 to 0.8.

Financials

Financial year 2025

APOTHEEK HAVENDAM from Brugge, company number BE0889942633, closed financial year 2025 with a result of € 28,512 after tax. For that financial year APOTHEEK HAVENDAM recorded a gross margin of € 93,021 and equity of € 198,987. Compared with financial year 2024, the result moved from € 32,634 to € 28,512. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 21, 2026.

What it is worth Growing

€ 198,987

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 28,512

▼ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 99,770

▼ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 15,000 paid out

53 % of the profit went to the shareholders, mostly to Portpharma (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

0.8

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 59,921

▲ 7% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 35,577

▼ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,462

▲ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 123,386 Gross margin 2022: € 123,386 First fiscal year in the series	€ 108,691 Gross margin 2023: € 108,691 ▼ 12% vs 2022 (€ 123,386) Unfavourable step	€ 92,741 Gross margin 2024: € 92,741 ▼ 15% vs 2023 (€ 108,691) Unfavourable step	€ 93,021 Gross margin 2025: € 93,021 Unchanged (€ 92,741) Favourable step
Profit after taxes	€ 50,089 Profit after taxes 2022: € 50,089 First fiscal year in the series	€ 34,910 Profit after taxes 2023: € 34,910 ▼ 30% vs 2022 (€ 50,089) Unfavourable step	€ 32,634 Profit after taxes 2024: € 32,634 ▼ 7% vs 2023 (€ 34,910) Unfavourable step	€ 28,512 Profit after taxes 2025: € 28,512 ▼ 13% vs 2024 (€ 32,634) Unfavourable step	▼ 13%
Equity	€ 157,932 Equity 2022: € 157,932 First fiscal year in the series	€ 172,842 Equity 2023: € 172,842 ▲ 9% vs 2022 (€ 157,932) Favourable step	€ 185,476 Equity 2024: € 185,476 ▲ 7% vs 2023 (€ 172,842) Favourable step	€ 198,987 Equity 2025: € 198,987 ▲ 7% vs 2024 (€ 185,476) Favourable step	▲ 7%
Total debts	€ 91,490 Total debts 2022: € 91,490 First fiscal year in the series	€ 84,107 Total debts 2023: € 84,107 ▼ 8% vs 2022 (€ 91,490) Favourable step	€ 88,386 Total debts 2024: € 88,386 ▲ 5% vs 2023 (€ 84,107) Unfavourable step	€ 64,065 Total debts 2025: € 64,065 ▼ 28% vs 2024 (€ 88,386) Favourable step	▼ 28%
Cash	€ 83,541 Cash 2022: € 83,541 First fiscal year in the series	€ 87,968 Cash 2023: € 87,968 ▲ 5% vs 2022 (€ 83,541) Favourable step	€ 114,003 Cash 2024: € 114,003 ▲ 30% vs 2023 (€ 87,968) Favourable step	€ 99,770 Cash 2025: € 99,770 ▼ 12% vs 2024 (€ 114,003) Unfavourable step	▼ 12%
Retained profit	€ 151,732 Retained profit 2022: € 151,732 First fiscal year in the series	€ 166,642 Retained profit 2023: € 166,642 ▲ 10% vs 2022 (€ 151,732) Favourable step	€ 179,276 Retained profit 2024: € 179,276 ▲ 8% vs 2023 (€ 166,642) Favourable step	€ 192,787 Retained profit 2025: € 192,787 ▲ 8% vs 2024 (€ 179,276) Favourable step	▲ 8%
Dividend	€ 30,000 Dividend 2022: € 30,000 First fiscal year in the series	€ 20,000 Dividend 2023: € 20,000 ▼ 33% vs 2022 (€ 30,000) Unchanged	€ 20,000 Dividend 2024: € 20,000 Unchanged (€ 20,000) Unchanged	€ 15,000 Dividend 2025: € 15,000 ▼ 25% vs 2024 (€ 20,000) Unchanged	▼ 25%
Balance sheet total	€ 249,421 Balance sheet total 2022: € 249,421 First fiscal year in the series	€ 256,949 Balance sheet total 2023: € 256,949 ▲ 3% vs 2022 (€ 249,421) Unchanged	€ 273,862 Balance sheet total 2024: € 273,862 ▲ 7% vs 2023 (€ 256,949) Unchanged	€ 263,053 Balance sheet total 2025: € 263,053 ▼ 4% vs 2024 (€ 273,862) Unchanged	▼ 4%
Employees (FTE)	1.1 Employees (FTE) 2022: 1.1 First fiscal year in the series	1 Employees (FTE) 2023: 1 ▼ 0.1 vs 2022 (1.1) Unchanged	0.9 Employees (FTE) 2024: 0.9 ▼ 0.1 vs 2023 (1) Unchanged	0.8 Employees (FTE) 2025: 0.8 ▼ 0.1 vs 2024 (0.9) Unchanged	▼ 0.1

Key figures of APOTHEEK HAVENDAM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK HAVENDAM?

What happened at APOTHEEK HAVENDAM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 21, 2026 New annual accounts for financial year 2025: profit of € 28,512 (▼ 13% vs 2024). Source: NBB ↗
Jul 1, 2007 New establishment in Brugge. KBO
May 24, 2007 Start of the company according to the CBE. KBO

In short

From € 50,089 profit in 2022 to € 28,512 profit in 2025.

Paid € 20,361 in corporate taxes since 2022.

Best year ever: 2022, with € 50,089 profit.

On average € 108,700 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

Portpharma 99.8%

The stake of Portpharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK HAVENDAM

Behind APOTHEEK HAVENDAM is Pic-Quick BV. The shares are held by Portpharma (99.8%).

Directors

According to the 2025 annual accounts

Pic-Quick BV

Director · represented by Evelien De Smet

Shareholders

Portpharma

99.8%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kustlaan 161

8380 Brugge

2.164.771.071

Brusselstraat 34

8380 Brugge

Active since 1 July 2007

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Portpharma same network

€ 290,034 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0889.942.633

VAT number

BE 0889.942.633

Registered office

Kustlaan 161, 8380 Brugge

Names & denominations

APOTHEEK HAVENDAM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 May 2007

Peppol

Active · Active since 17 Feb 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in cosmetica en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK HAVENDAM

Warning lights

Financials

What happened to APOTHEEK HAVENDAM?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions